Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia.
Stefan Faderl(Jazz Pharmaceuticals (United States)), Zeev Estrov(The University of Texas MD Anderson Cancer Center), Moshe Talpaz(University of Michigan), Steven M. Kornblau(The University of Texas MD Anderson Cancer Center), Quin Van, David Harris, M Beran, Peter F. Thall(The University of Texas MD Anderson Cancer Center), H. Kantarjian(The University of Texas MD Anderson Cancer Center), Gareth Pierce
PubMed
December 1, 1999
Cited by 74
Related Papers
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
|Nature Genetics|2013|1.2k
Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing
|Nature Genetics|2013|818
Identification of Targetable FGFR Gene Fusions in Diverse Cancers
|Cancer Discovery|2013|737
Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study
|Science Translational Medicine|2011|637
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
|Nature Genetics|2019|616